Prions: Protein Aggregation and Infectious Diseases - Physiological ...

1152 ADRIANO AGUZZI AND ANNA MARIA CALELLA
492. Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical
basis of how prion conformations determine strain phenotypes.
Nature 442: 585–589, 2006.
493. Taraboulos A, Jendroska K, Serban D, Yang SL, DeArmond
SJ, Prusiner SB. Regional mapping of prion proteins in brain.
Proc Natl Acad Sci USA 89: 7620–7624, 1992.
494. Taraboulos A, Raeber AJ, Borchelt DR, Serban D, Prusiner
SB. Synthesis and trafficking of prion proteins in cultured cells.
Mol Biol Cell 3: 851–863, 1992.
495. Taraboulos A, Scott M, Semenov A, Avraham D, Laszlo L,
Prusiner SB. Cholesterol depletion and modification of COOHterminal
targeting sequence of the prion protein inhibit formation
of the scrapie isoform. J Cell Biol 129: 121–132, 1995.
496. Tateishi J, Doh-ura K. Prion protein gene analysis and transmission
studies of Creutzfeldt-Jakob disease. In: Prion Diseases of
Humans and Animals, edited by Prusiner SB, Collinge J. London:
Horwood, 1992, p. 129–134.
497. Taylor DM, McConnell I, Fraser H. Scrapie infection can be
established readily through skin scarification in immunocompetent
but not immunodeficient mice. J Gen Virol 77 1595–1599, 1996.
498. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M,
Rülicke T, Moser M, Oesch B, McBride PA, Manson JC. Altered
circadian activity rhythms and sleep in mice devoid of prion protein.
Nature 380: 639–642, 1996.
499. Toyama BH, Kelly MJ, Gross JD, Weissman JS. The structural
basis of yeast prion strain variants. Nature 449: 233–237, 2007.
500. Trifilo MJ, Yajima T, Gu Y, Dalton N, Peterson KL, Race RE,
Meade-White K, Portis JL, Masliah E, Knowlton KU, Chesebro
B, Oldstone MB. Prion-induced amyloid heart disease with
high blood infectivity in transgenic mice. Science 313: 94–97, 2006.
501. Tuzi NL, Cancellotti E, Baybutt H, Blackford L, Bradford B,
Plinston C, Coghill A, Hart P, Piccardo P, Barron RM, Manson
JC. Host PrP glycosylation: a major factor determining the outcome
of prion infection. PLoS Biol 6: e100, 2008.
502. Vernau W, Jacobs RM, Valli VE, Heeney JL. The immunophenotypic
characterization of bovine lymphomas. Vet Pathol 34: 222–
225, 1997.
503. Vnencak Jones CL, Phillips JAD. Identification of heterogeneous
PrP gene deletions in controls by detection of allele-specific
heteroduplexes (DASH). Am J Hum Genet 50: 871–872, 1992.
504. Wadsworth JD, Asante EA, Desbruslais M, Linehan JM,
Joiner S, Gowland I, Welch J, Stone L, Lloyd SE, Hill AF,
Brandner S, Collinge J. Human prion protein with valine 129
prevents expression of variant CJD phenotype. Science 306: 1793–
1796, 2004.
505. Wadsworth JD, Hill AF, Joiner S, Jackson GS, Clarke AR,
Collinge J. Strain-specific prion-protein conformation determined
by metal ions. Nat Cell Biol 1: 55–59, 1999.
506. Waggoner DJ, Drisaldi B, Bartnikas TB, Casareno RL, Prohaska
JR, Gitlin JD, Harris DA. Brain copper content and cuproenzyme
activity do not vary with prion protein expression level.
J Biol Chem 275: 7455–7458, 2000.
507. Wagner N, Lohler J, Kunkel EJ, Ley K, Leung E, Krissansen
G, Rajewsky K, Muller W. Critical role for beta7 integrins in
formation of the gut-associated lymphoid tissue. Nature 382: 366–
370, 1996.
508. Ware CF, VanArsdale TL, Crowe PD, Browning JL. The ligands
and receptors of the lymphotoxin system. Curr Top Microbiol
Immunol 198: 175–218, 1995.
509. Wasmer C, Lange A, Van Melckebeke H, Siemer A, Riek R,
Meier B. Amyloid fibrils of the HET-s(218–289) prion form a beta
solenoid with a triangular hydrophobic core. Science 319: 1523–
1526., 2008.
510. Weissmann C. Birth of a prion: spontaneous generation revisited.
Cell 122: 165–168, 2005.
511. Weissmann C. Spongiform encephalopathies. The prion’s
progress. Nature 349: 569–571, 1991.
512. Weissmann C. A “unified theory” of prion propagation. Nature
352: 679–683, 1991.
513. Weissmann C, Aguzzi A. Perspectives: neurobiology. PrP’s double
causes trouble. Science 286: 914–915, 1999.
Physiol Rev VOL 89 OCTOBER 2009 www.prv.org
514. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD,
Jeffrey M, Dawson M, Bradley R. A novel progressive spongiform
encephalopathy in cattle. Vet Rec 121: 419–420, 1987.
515. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson
GA, Prusiner SB, et al. Distinct prion proteins in short and
long scrapie incubation period mice. Cell 51: 651–662, 1987.
516. Westaway D, Mirenda CA, Foster D, Zebarjadian Y, Scott M,
Torchia M, Yang SL, Serban H, DeArmond SJ, Ebeling C.
Paradoxical shortening of scrapie incubation times by expression
of prion protein transgenes derived from long incubation period
mice. Neuron 7: 59–68, 1991.
517. Westermark P, Sletten K, Johansson B, Cornwell GG 3rd.
Fibril in senile systemic amyloidosis is derived from normal transthyretin.
Proc Natl Acad Sci USA 87: 2843–2845, 1990.
518. White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner
S, Anstee D, Collinge J, Hawke S. Monoclonal antibodies
inhibit prion replication and delay the development of prion disease.
Nature 422: 80–83, 2003.
519. White MD, Farmer M, Mirabile I, Brandner S, Collinge J,
Mallucci GR. Single treatment with RNAi against prion protein
rescues early neuronal dysfunction and prolongs survival in mice
with prion disease. Proc Natl Acad Sci USA 105: 10238–10243,
2008.
520. Whittington MA, Sidle KC, Gowland I, Meads J, Hill AF,
Palmer MS, Jefferys JG, Collinge J. Rescue of neurophysiological
phenotype seen in PrP null mice by transgene encoding human
prion protein. Nat Genet 9: 197–201, 1995.
521. Wilesmith JW, Ryan JB, Hueston WD, Hoinville LJ. Bovine
spongiform encephalopathy: epidemiological features 1985 to 1990.
Vet Rec 130: 90–94, 1992.
522. Will R, Zeidler M. Diagnosing Creutzfeldt-Jakob disease. BMJ 313:
833–834, 1996.
523. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K,
Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A
new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:
921–925, 1996.
524. Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban
A, Cohen FE, Agard DA, Prusiner SB. Structural studies of
the scrapie prion protein by electron crystallography. Proc Natl
Acad Sci USA 99: 3563–3568, 2002.
525. Williams ES, Young S. Chronic wasting disease of captive mule
deer: a spongiform encephalopathy. J Wildl Dis 16: 89–98, 1980.
526. Williams RC. Electron microscopy of viruses. Adv Virus Res 2:
183–239, 1954.
527. Wilson DR, Anderson RD, Smith W. Studies in Scrapie. J Comp
Pathol 60: 267–282, 1950.
528. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S,
Linehan JM, Brandner S, Wadsworth JD, Hewitt P, Collinge
J. Clinical presentation and pre-mortem diagnosis of variant
Creutzfeldt-Jakob disease associated with blood transfusion: a case
report. Lancet 368: 2061–2067, 2006.
529. Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A.
Proteasomes and ubiquitin are involved in the turnover of the
wild-type prion protein. EMBO J 20: 5383–5391, 2001.
530. Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P,
Kranich J, von Teichman A, Haas KM, Zeller N, Tedder TF,
Weis JH, Aguzzi A. Stromal complement receptor CD21/35 facilitates
lymphoid prion colonization and pathogenesis. J Immunol
179: 6144–6152, 2007.
531. Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez
Garcia F, Billeter M, Calzolai L, Wider G, Wuthrich K. NMR
solution structure of the human prion protein. Proc Natl Acad Sci
USA 97: 145–150, 2000.
532. Zanusso G, Ferrari S, Cardone F, Zampieri P, Gelati M,
Fiorini M, Farinazzo A, Gardiman M, Cavallaro T, Bentivoglio
M, Righetti PG, Pocchiari M, Rizzuto N, Monaco S.
Detection of pathologic prion protein in the olfactory epithelium
in sporadic Creutzfeldt-Jakob disease. N Engl J Med 348: 711–
719, 2003.
533. Zhang B, Une Y, Fu X, Yan J, Ge F, Yao J, Sawashita J, Mori
M, Tomozawa H, Kametani F, Higuchi K. Fecal transmission of
AA amyloidosis in the cheetah contributes to high incidence of
disease. Proc Natl Acad Sci USA 105: 7263–7268, 2008.